Authors
Latest:
A New Era in European Life Sciences InvestmentInvestments setting up sector for future success that could one day rival its US counterpart.
Latest:
How Medical Affairs Can Contribute to Successful Drug LaunchFaster launch planning leads to greater access.
Latest:
New Technologies Come with New Litigation RisksCybersecurity vulnerabilities embedded in AI and machine learning pose significant litigation risks as life sciences companies move to digital technologies.
Latest:
Navigating the European Market for Medical CannabisThere is considerable variation in the regulatory approach to medical cannabis between European countries. Yet, despite the complexity, there are clear routes to market, reports Peter Kohut.
Latest:
The Global Vaccine R&D Pipeline and Delivery ImplicationsThe current vaccine pipeline brings promise of significant global health advancements—yet development gaps remain, and the future delivery challenges must be considered.
Latest:
US Pharma and Biotech Summit 2024: A Biotech Industry OverviewKOLs in the sector examine the current dealmaking landscape, including the status of available capital.
Latest:
How AI is Changing the Drug Development JourneyWhile no company has yet achieved the full promise of AI to radically accelerate time to market, meaningful strides are being made across the drug discovery funnel.
Latest:
The Role of AI in Helping Clinicians Diagnose PatientsThree ways artificial intelligence can drive the necessary engagement between patients and HCPs.
Latest:
The Emergence of the Chief Value Officer in HealthcareOutlining the implications of this c-suite trend for pharma.
Latest:
The Future of Safety and Adverse Event ProcessesAddressing the increased use of technology in safety compliance processes and greater patient involvement.
Latest:
How Biopharma Can Rev Up the Analytics Engine to Boost Patient ComplianceWhile patient support providers play an important role in keeping patients on therapy, biopharma companies have a great opportunity to push analytical sophistication beyond what many of these providers currently offer.
Latest:
Partnerships Are Key to Niche Markets in BrazilForging effective partnerships with local companies is particularly important when entering Brazil’s pharma market. Sameer Kolhe reports.
Latest:
Has Pharma Given Up on Long-Term Adherence?Will the FDA ultimately step in and mandate a credible effort to eradicate the mindset that long-term adherence is not achievable?
Latest:
Why Pharma Must Invest in Key Account Management CapabilitiesThe emergence of organized customers demands investment in advanced solutions and next-generation key account management.
Latest:
How to Improve Life Sciences Promotional Review Committees Using Service Operations PrinciplesA deep-dive into how pharma companies can apply service operations principles to achieve a greater level of marketing and promotional review committee satisfaction.
Latest:
Digital-Communication Check: Insights Learned During LockdownA look at the results of recent surveys revealing the impact of the COVID-triggered digital switchover on sales rep interactions and medical conferences.
Latest:
To Build AI Maturity, Start With Quick WinsCompanies must determine the right ways to utilize AI.
Latest:
Tuning and Tracking CAR-T Cells for Safer and More Effective Treatment for Solid TumorsWith technological advancements in affinity tuning and real-time tracking of CAR-T cells, the hope is that CAR-T therapy can be effectively applied to treating solid tumors, improve patient outcomes, and avoid the toxicities seen with certain treatments in the clinic.
Latest:
PREP Act Protections for COVID-19 Vaccine LiabilityHow PREP Act protections will apply to potential COVID-19 vaccine-related claims.
Latest:
Building the Pharma Talent of Tomorrow from Today’s WorkforceHiring new employees may not be the answer to the war for talent.
Latest:
How Biopharma Can Accelerate Innovation and Sustain GrowthThere are clear pathways that biopharma companies can take to sustain growth and remain competitive.
Latest:
Fortifying Defenses Pre-Patent CliffIntegrating artificial intelligence and advanced analytics throughout operations offers pharma companies a pathway to offset impending drug patent expirations.
Latest:
Embedded and agile–The next phase of the DCT evolutionEllenor discusses key points from the recent SCOPE presentation.
